Business
PTX to resume Clinical Trial of PTX-200 in Ovarian Cancer
PTX to resume Clinical Trial of PTX-200 in Ovarian Cancer
About this update from Prescient Therapeutics Limited
[{"type":"text","content":"Prescient Therapeutics Ltd has released a press release. View Attachment","length":254,"tagName":"div"}]